Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands
Open Access
- 1 May 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (19) , 12601-12605
- https://doi.org/10.1074/jbc.272.19.12601
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A Strategy for Designing Inhibitors of β-Amyloid ToxicityJournal of Biological Chemistry, 1996
- Arrest of -Amyloid Fibril Formation by a Pentapeptide LigandJournal of Biological Chemistry, 1996
- Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and NeurotoxicityJournal of Neurochemistry, 1995
- Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in VitroBiochemical and Biophysical Research Communications, 1994
- β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptideFEBS Letters, 1994
- Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?Cell, 1993
- Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formationBiochemical and Biophysical Research Communications, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984